The Effect of Infant Formulas With 4 or 8 g/L GOS/FOS on Growth, Gastrointestinal Symptoms, and Behavioral Patterns: A Prospective Cohort Study
There is a lack of studies investigating the clinical benefits of prebiotic-supplemented infant formula. In this study, healthy infants that started, on medical recommendation, artificial feeding with one of 2 infant formulas containing 4 g/L of GOS/FOS (9:1) (IF4 group; n = 60) or 8 g/L of GOS/FOS...
Saved in:
Main Authors: | Karina Merini Tonon PhD (Author), Thaís Moreno Tomé BSND (Author), Elaine Martins Bento Mosquera (Author), Natália Pratis Perina PhD (Author), Tamara Lazarini MSc (Author) |
---|---|
Format: | Book |
Published: |
SAGE Publishing,
2021-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A young child formula supplemented with a synbiotic mixture of scGOS/lcFOS and Bifidobacterium breve M-16V improves the gut microbiota and iron status in healthy toddlers
by: Charmaine Chew, et al.
Published: (2024) -
Effects of oral supplementation with FOS and GOS prebiotics in women with adult acne: the “S.O. Sweet” study: a proof-of-concept pilot trial
by: Dall'Oglio F, et al.
Published: (2018) -
Gastrointestinal Tolerance of Formula-Fed Infants During the Immediate Postnatal Period in Saudi Arabia: An Observational Study
by: Nicholas P. Hays PhD, et al.
Published: (2024) -
Amino Acid Formulas in Patients with Gastrointestinal Diseases
by: Alexander A. Baranov, et al.
Published: (2021) -
Bleeding Risk Related to Upper Gastrointestinal Endoscopic Biopsy in Patients Receiving Antithrombotic Therapy: A Multicenter Prospective Observational Study
by: Takafumi Yuki, MD, PhD, et al.
Published: (2017)